Fosrenol Shire Pharmaceuticals Group plc - Treatment for Hyperphosphataemia in ESRD Patients

Fosrenol is a non-calcium, non-aluminum phosphate binder formulated as an easy to use, chewable only tablet that can be taken without water. Fosrenol is used to reduce high phosphorus levels in end-stage renal disease (ESRD) patients.

Posted: October 2004

Related Articles:

Fosrenol (lanthanum carbonate) FDA Approval History

View comments

Hide
(web3)